Clonidine and Pericardial effusion - a phase IV clinical study of FDA data
Summary:
We study 60,680 people who have side effects when taking Clonidine. Pericardial effusion is found, especially among people who are female, 60+ old, have been taking the drug for < 1 month, also take Lasix and have Rheumatoid arthritis.
The phase IV clinical study analyzes which people take Clonidine and have Pericardial effusion. It is created by eHealthMe based on reports from the FDA, and is updated regularly. You may use the study as a second opinion to make health care decisions.
Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 700+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.
60,680 people reported to have side effects when taking Clonidine.
Among them, 164 people (0.27%) have Pericardial effusion.
What is Clonidine?
Clonidine has active ingredients of clonidine. It is used in high blood pressure. Currently, eHealthMe is studying from 62,354 Clonidine users.
What is Pericardial effusion?
Pericardial effusion (fluid around the heart) is found to be associated with 2,085 drugs and 1,400 conditions by eHealthMe. Currently, we are studying 27,639 people who have Pericardial effusion.
Number of Clonidine and Pericardial effusion reports submitted per year:
Time on Clonidine when people have Pericardial effusion *:
Gender of people who have Pericardial effusion when taking Clonidine*:
Age of people who have Pericardial effusion when taking Clonidine *:
Common drugs people take besides Clonidine *:
Common side effects people have besides Pericardial effusion *:
Common conditions people have *:
* Approximation only. Some reports may have incomplete information.
Do you take Clonidine and have Pericardial effusion?
Check whether Pericardial effusion is associated with a drug or a conditionHow to use the study?
You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.
Related publications that referenced our studies
- Teimoory M, Arefi M, Behnoush B, Bastani B, "Promethazine and Treatment Refractory Agitation in Clonidine Toxicity", International Journal of Medical Toxicology and Forensic Medicine, 2013 Mar .
Related studies
Clonidine side effects by duration, gender and age:
- Clonidine side effects (62,354 reports)
Pericardial effusion treatments and more:
- Pericardial effusion (27,639 reports)
Common drugs associated with Pericardial effusion:
- Aspirin: 1,681 reports
- Prednisone: 1,524 reports
- Lasix: 1,336 reports
- Furosemide: 1,275 reports
- Methotrexate: 972 reports
- Amlodipine: 951 reports
- Cyclophosphamide: 773 reports
- Omeprazole: 733 reports
- Metformin: 709 reports
- Lisinopril: 695 reports
All the drugs that are associated with Pericardial effusion:
- Pericardial effusion (2,085 drugs)
Common conditions associated with Pericardial effusion:
- Primary pulmonary hypertension: 1,518 reports
- High blood pressure: 1,364 reports
- Rheumatoid arthritis: 1,105 reports
- Atrial fibrillation/flutter: 883 reports
- Pain: 620 reports
All the conditions that are associated with Pericardial effusion:
- Pericardial effusion (1,400 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on clonidine (the active ingredients of Clonidine) and Clonidine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 700+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Prochlorperazine Maleate and High Blood Pressure - 4 seconds ago
- Tysabri and Intestinal Stenosis - 8 seconds ago
- Xyrem and Varenicline drug interaction - 19 seconds ago
- Nitrolingual and Fibromyalgia - 22 seconds ago
- Megestrol Acetate and Palmar-Plantar Erythrodysaesthesia Syndrome - 24 seconds ago
- Gabapentin and Renal Cancer Stage Iv - 29 seconds ago
- Ceftriaxone Sodium and Hydrocortisone drug interaction - 35 seconds ago
- Fenofibrate and Neosporin drug interaction - 51 seconds ago
- Valsartan and Fistula Discharge - 52 seconds ago
- Keflex and Bone Cyst - 58 seconds ago